SCHEMBL1034852

SCHEMBL1034852

CCOC(=O)C(C)(C)Oc1ccc(C(=O)CCc2sc3ccccc3c2C)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 5/20 0.41
CNR2 P34972 3/20 0.37
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 3/20 0.37
NOD2 Q9HC29 1/20 0.37
CYP1A2 P05177 3/20 0.36
LMNA P02545 2/20 0.36
PPARA Q07869 3/20 0.35
MAPT P10636 3/20 0.35
PPARG P37231 2/20 0.35
MEN1 O00255 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TP53 P04637 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
ABCB11 O95342 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
HTR2A P28223 1/20 0.34
PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1035257 0.89 PTPN7 (0.44) CNR2ALDH1A1CYP1A2PPARAPPARG
SCHEMBL20292499 0.87 FBP1 (0.38) FBP1PPARAPPARG
SCHEMBL1030579 0.87 FBP1 (0.38) FBP1LMNAPPARAPPARGTP53
SCHEMBL1034038 0.83 ABCB1 (0.46) CNR2ALDH1A1KMT2ANOD2CYP1A2
SCHEMBL1031807 0.79 CYP1A2 (0.45) KMT2ACYP1A2PPARAPPARGMEN1
SCHEMBL1035525 0.77 CYP1A2 (0.45) CNR2ALDH1A1KMT2ANOD2CYP1A2
SCHEMBL1031757 0.76 PPARD (0.46) PPARAPPARG
SCHEMBL1030631 0.76 PPARD (0.44) PPARAPPARG
SCHEMBL5187932 0.76 FBP1 (0.55) FBP1KMT2ACYP1A2PPARAPPARG
SCHEMBL4106067 0.75 PPARD (0.41) FBP1KMT2APPARAMAPTPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3424917-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2019-01-09 EP disclosed
EP-2277874-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO (JP) 2018-06-27 EP disclosed
US-8648208-B2 Activating agent for peroxisome proliferator activated receptor NIPPON CHEMIPHAR CO. LTD. (JP) 2014-02-11 US disclosed
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR NIPPON CHEMIPHAR CO. LTD. (JP) 2011-04-28 US disclosed
EP-2277874-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Nippon Chemiphar Co., Ltd. (JP) 2011-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098480-A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR PPARA, PPARG, PPARD FBP1 1837/4885CNR2 351/4885ALDH1A1 657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.